Please use this identifier to cite or link to this item:
|標題:||H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells||作者:||Li, C.
|關鍵字:||H-Ras;bladder transitional cell carcinoma;genistein;microarray;profiling gene expression pattern;drug resistance;tyrosine kinase inhibitor;human urinary-bladder;transcriptional;activation;gene-expression;cancer risk;in-vitro;c-fos;k-ras;protein;lines||Project:||British Journal of Cancer||期刊/報告no：:||British Journal of Cancer, Volume 92, Issue 1, Page(s) 80-88.||摘要:||
Among eight human bladder cancer cell lines we examined, only T24 cells were resistant to the growth inhibition effect of genistein, an isoflavone and potent anticancer drug. Since the T24 cell line was the only cell line known to overexpress oncogenic H-Ras(val12), we investigated the role of H-Ras(val 12) in mediating drug resistance. Herein, we demonstrate that the phenotype of T24 cells could be dramatically reversed and became relatively susceptible to growth inhibition by genistein if the synthesis of H- Ras(val 12) or its downstream effector c-Fos had been suppressed. The inhibition of Ras-mediated signalling with protein kinase inhibitors, such as PD58059 and U0126 which inhibited MEK and ERK, in T24 cells also rendered the identical phenotypic reversion. However, this reversion was not observed when an inhibitor was used to suppress the protein phosphorylation function of PI3 K or PKC. These results suggest that the signal mediated by H-Ras(val 12) is predominantly responsible for the resistance of the cells to the anticancer drug genistein.
|Appears in Collections:||期刊論文|
Show full item record
TAIR Related Article
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.